NeuroOne Medical Technologies Corporation
NMTC
Rank in Stocks
#29396
NeuroOne Medical Technologies Corporation functions as a specialized medical... NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
Share Price
$0.8852
Last synced: 2026-11-09
Market Cap
$8.06M
Change (1 day)
0.71%
Change (1 year)
-79.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NeuroOne Medical Technologies Corporation (NMTC)
Category
Healthcare
Operating Margin for NeuroOne Medical Technologies Corporation (NMTC)
Operating Margin as of November 2026 TTM: -76.05%
According to NeuroOne Medical Technologies Corporation's latest financial reports, its current operating margin (TTM) is -76.05%. At the end of 2025 the company had an operating margin of -34.94%.
Operating Margin history for NeuroOne Medical Technologies Corporation from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -76.05% | 117.66% |
| 2025 | -34.94% | -89.85% |
| 2024 | -344.26% | -43.78% |
| 2023 | -612.32% | -89.55% |
| 2022 | -5,860.15% | 2.17% |
| 2021 | -5,735.86% | 2,154.13% |
| 2020 | -254.46% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -4,166.44% | -10.32% |
| 2014 | -4,646.05% | 195.58% |
| 2013 | -1,571.82% | 5.41% |
| 2012 | -1,491.10% | 193.46% |
| 2011 | -508.11% | -1.89% |
| 2010 | -517.91% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.20% |
US
|
|
| 18.08% | -100.24% |
IE
|
|
| 21.25% | -100.28% |
US
|
|
| 21.05% | -100.28% |
US
|
|
| 28.09% | -100.37% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about NeuroOne Medical Technologies Corporation's operating margin
What is NeuroOne Medical Technologies Corporation's operating margin?
NeuroOne Medical Technologies Corporation's operating margin is -76.05%, as of Nov 2026.
What was NeuroOne Medical Technologies Corporation's operating margin in 2025?
In 2025, NeuroOne Medical Technologies Corporation's operating margin was -34.94%, compared with -344.26% in 2024.
How has NeuroOne Medical Technologies Corporation's operating margin changed since 2020?
From 2020 to 2025, NeuroOne Medical Technologies Corporation's operating margin was highest in 2025 (-34.94%) and lowest in 2022 (-5,860.15%).
How does NeuroOne Medical Technologies Corporation's operating margin compare with similar companies?
NeuroOne Medical Technologies Corporation's operating margin (-76.05%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.